April 14, 2021
AstraZeneca’s non-small cell lung cancer approved in China
AstraZeneca’s Tagrisso has been approved in China for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 14, 2021
FDA pauses vaccination with J&J vaccine after six cases of blood clot
U.S. CDC and FDA called for a pause in the J&J’s vaccine use following the emergence of a rare blood clotting disorder in six recipients.
April 14, 2021
Sodium-bicarbonate can help reduce Covid symptoms, study shows
A certain peer-reviewed study (see more here) carried out at the Welcare Hospital, India, found out that kitchen staple, bicarbonate of soda is found to significantly reduce Covid-19 symptoms.
April 14, 2021
VectivBio Announces Closing of $146.6 Million Initial Public Offering
BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG, (“Vectiv” or “VectivBio”) (Nasdaq: VECT), a clinical stage biopharmaceutical…
April 13, 2021
Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and Obesity
Company announcement – No. 21/ 2021 Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and…
April 1, 2021
J&J answers allegations over vaccine problems
J&J has answered allegations about its batch of vaccines that could not be used after ingredient issues.
March 31, 2021
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
EMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines…
March 31, 2021
GSK to support manufacture of Novavax’ COVID-19 vaccine
GSK has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up…
March 29, 2021
FDA approves new indication for Astellas Pharma’s bladder dysfunction drug
The U.S. Food and Drug Administration approved a new indication for Astellas Pharma’s Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older.
March 26, 2021
AstraZeneca pushes back vaccines-in-Italy topic
AstraZeneca has issued a statement to clarify a number of inaccurate statements relating to COVID-19 Vaccine AstraZeneca doses at the Anagni plant in Italy.